title: [Lymphadenopathy due to sulfasalazine in rheumatoid polyarthritis].
authors.forename: A
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: G
authors.initials: G
authors.lastname: Bolla
authors.forename: N
authors.initials: N
authors.lastname: Horschowski
authors.forename: C
authors.initials: C
authors.lastname: Fossat
authors.forename: M
authors.initials: M
authors.lastname: David
authors.forename: V
authors.initials: V
authors.lastname: Salvator
authors.forename: A
authors.initials: A
authors.lastname: Schiano
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006965:Hyperplasia; D008206:Lymphatic Diseases / Q000139:chemically induced*; D012460:Sulfasalazine / Q000009:adverse effects*
chemical_list: D012460:Sulfasalazine
vernacular_title: Lymphadénopathies sous sulfasalazine au cours d'une polyarthrite rhumatoïde.